Truist Financial Corp Mei Pharma, Inc. Transaction History

Truist Financial Corp

  • $65 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$0.54 - $2.74 $31,998 - $162,364
-59,257 Closed
0 $0
Q4 2020

Nov 19, 2021
SELL
$2.6 - $3.32 $19,929 - $25,447
-7,665 Reduced 11.45%
59,257 $156,000
Q4 2020

Feb 18, 2021
BUY
$2.6 - $3.32 $97,929 - $125,047
37,665 Added 128.74%
66,922 $176,000
Q4 2019

Feb 14, 2020
BUY
$1.65 - $2.48 $48,274 - $72,557
29,257 New
29,257 $72,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Truist Financial Corp Portfolio

Follow Truist Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email